Latest Cancer vaccine Stories
GAITHERSBURG, Md., Feb. 10, 2015 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. and Accelovance Inc.
Established business leader brings more than 40 years of pharmaceutical operations and commercialization expertise to the company FREDERICK, Md., Feb.
Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.
SAN DIEGO, Feb. 4, 2015 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
ImmunoDiet treats cancer with nutrition based on genetic data. Houston, Texas (PRWEB) February 03, 2015 Personal Peptides, a provider of precision medicine
New treatment technique developed in partnership with Cancer Immune Biologics ATLANTA, Feb.
Proceeds will Fund ACTIVE: the Phase IIIb OncoVAX® Trial and Company Expansion FREDERICK, Md., Jan.
DALLAS, January 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance
- Growing in low tufty patches.